Assay measures phosphorylated tau 217, an indicator of amyloid pathology

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings